Interview with Laura Hawks, MD, author of Trends in Unmet Need for Physician and Preventive Services in the United States, 1998-2017, and John Z. Ayanian, MD, MPP, author of Looking Back to Improve Access to Health Care Moving Forward

Interview with Nima Sharifi, M.D., author of HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Interview with Sharon Saydah, PhD, MHS, author of Eye Care Among US Adults at High Risk for Vision Loss in the United States in 2002 and 2017

Interview with Jason Ying Kuen Chan, MBBS, author of Practical Aspects of Otolaryngologic Clinical Services During the 2019 Novel Coronavirus Epidemic: An Experience in Hong Kong

Interview with Robert O. Bonow, MD, Patrick T. O'Gara, MD, Clyde W. Yancy, MD, and Gregg C. Fonarow, MD, authors of Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality and Ajay J. Kirtane, MD

Interview with Alfred Sommer, MD, author of Humans, Viruses, and the Eye—An Early Report From the COVID-19 Front Line

Interview with Joshua K Tay, author of Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak, and Babak Givi, MD, author of Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic

Interview with Hsien-Ho Lin, MD, ScD, author of Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset

The Minister also asked the States to ensure adoption of infection, prevention and control (IPC) practices in all health-care settings to avoid and reduce chances of infections to health-care workers.

Expectations of a slow recovery, high fixed costs and debt worries are putting off investors

This was the sixth successive year of net inflows in equity mutual funds

All that happened in the markets today

The broader structure of Nifty still looks weak though

On Thursday, UK-based Glaxo-SmithKline (GSK) offloaded its stake in HUL via block deals.

The bank's total revenue jumped 33 per cent YoY to Rs 1,522 crore from Rs 1,148 crore reported in Q4FY19, while its net interest income came in at Rs 1,021 crore, up 38 per cent YoY from Rs 739 crore

Till 12:44 pm, a combined 34.4 million equity shares, representing 32.2 per cent of total equity of Laurus Labs, changed hands on the BSE and NSE.

The company's March quarter (Q4F20) performance came below expectations on, both, revenue and margin terms largely due to the impact of Covid-19.

In all, these three entities have added Rs 5.8 trillion to their m-cap during the period, against a Rs 11.3-trillion rise in the incremental m-cap of all 30 Sensex companies